The key difference between bisphosphonates and denosumab is that bisphosphonates bind with the bone minerals, thereby interfering with the function of mature osteoclasts, while denosumab is a humanized monoclonal antibody that targets receptor activator of nuclear factor kappa-B ligand (RANKL) to suppress the function of osteoclasts. Osteoporosis is a condition in which bone resorption is […]

